SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-055111
Filing Date
2021-10-28
Accepted
2021-10-28 16:30:44
Documents
13
Period of Report
2021-10-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea149491-8k_inmunebio.htm   iXBRL 8-K 46806
2 PRESS RELEASE DATED OCTOBER 27, 2021 ea149491ex99-1_inmunebio.htm EX-99.1 26658
  Complete submission text file 0001213900-21-055111.txt   254220

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE inmb-20211027.xsd EX-101.SCH 3028
4 XBRL LABEL FILE inmb-20211027_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE inmb-20211027_pre.xml EX-101.PRE 22361
6 EXTRACTED XBRL INSTANCE DOCUMENT ea149491-8k_inmunebio_htm.xml XML 3717
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 211358765
SIC: 2836 Biological Products, (No Diagnostic Substances)